Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20171
20191
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anelixis Therapeutics, LLC1
Eli Lilly and Company1
Gary A Levy, O. Ont. MD. FRCP AGAF1
Immunovant Sciences GmbH1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases8
Immune System Diseases4
Arthritis, Rheumatoid2
Joint Diseases2
Rheumatic Diseases2
Arthritis1
Connective Tissue Diseases1
Diabetes Mellitus, Type 11
Endocrine System Diseases1
Fatigue1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.